Measuring the proportion of and reasons for asthma‐related school absence in England

Jones, Christina; Mabbitt, Jeremy; Kissling, Esther; Gilchrist, K; Scanlon, T. M.; Thomas, Gavin; Wooler, Edwina; Mcfarlane, R; Mukhopadhyay, Somnath

doi:10.1111/cea.13589

Cited by 3 publications

(4 citation statements)

References 7 publications

(6 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This cohort, in line with the literature and national data, reported significant impact of asthma on their lives 27 28. However, neither ethnicity nor income data were collected, and this work was undertaken in a single centre.…”

Section: Discussionmentioning

confidence: 60%

Pharmacogenomics and asthma treatment: acceptability to children, families and healthcare professionals

et al. 2022

View full text Add to dashboard Cite

BackgroundEvidence supporting personalised treatment for asthma based on an individual’s genetics is mounting. The views of children and young people (CYP), parents and healthcare professionals (HCPs) about this evolution of clinical care are not known.MethodsA pilot prospective questionnaire-based study was undertaken of CYP with asthma, their parents and HCPs at a secondary/tertiary children’s hospital in the UK.ResultsFifty-nine questionnaires were distributed and 50 returned (response rate 84.7%), comprising 26 CYP (10 were 5–11 years, 11 were 12–15 years and 5 were 16–18 years old), 13 parents and 11 HCPs. For all types of data, personal information was ranked as the ‘most important’ (n=19, 47.5%) and ‘most private’ (n=16, 40%), but with considerable variation across groups. Within health data, allergies were rated as ‘most important’ (n=12, 30.8%), and mental health records the ‘most private’ (n=21, 53.8%), again with variation across groups. A ‘personalised genetic asthma plan’ was acceptable to the majority overall (n=40, 80.0%). With regard to sharing CYP’s genetic data, 23 (46%) of participants were happy for unconditional sharing between HCPs, and 23 (46%) agreed to sharing solely in relation to the CYP’s asthma management. Forty-two (84.0%) of participants felt CYP should be informed about genetic data being shared, and the majority felt this should commence by 12 years of age.ConclusionThe use of genetic information to guide management of asthma in CYP is largely acceptable to CYP, parents/guardians and HCPs. However, there are key differences between the opinions of CYP, parents and HCPs.

show abstract

Section: Discussionmentioning

confidence: 60%

Pharmacogenomics and asthma treatment: acceptability to children, families and healthcare professionals

et al. 2022

View full text Add to dashboard Cite

show abstract

“…cough) allows for more detailed investigation. Studybugs has previously been used to measure the proportion of and reasons for asthma related school absence in England [9]. Other studies have used school absence data to illustrate the impact from certain conditions such as influenza [20][21][22].…”

Section: Discussionmentioning

confidence: 99%

“…Studybugs is a software platform for schools and includes an online free service (including an app) which is used by parents to report their children absent from school and prompts parents to report the reason for and symptoms related to that period of absence [ 8 ]. Based upon ‘reason for absence’, Studybugs is able to provide information to parents using symptom-specific PHE health protection recommendations [ 9 ]. Studybugs process the data and provide anonymised, open (freely available) data which are shared with schools and made available to other organisations with parental consent [ 8 ].…”

Section: Methodsmentioning

confidence: 99%

Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic

et al. 2021

Self Cite

View full text Add to dashboard Cite

This study describes the development of a pilot sentinel school absence syndromic surveillance system. Using data from a sample of schools in England the capability of this system to monitor the impact of disease on school absences in school-aged children is shown, using the coronavirus disease 2019 (COVID-19) pandemic period as an example. Data were obtained from an online app service used by schools and parents to report their children absent, including reasons/symptoms relating to absence. For 2019 and 2020, data were aggregated into daily counts of ‘total’ and ‘cough’ absence reports. There was a large increase in the number of absence reports in March 2020 compared to March 2019, corresponding to the first wave of the COVID-19 pandemic in England. Absence numbers then fell rapidly and remained low from late March 2020 until August 2020, while lockdown was in place in England. Compared to 2019, there was a large increase in the number of absence reports in September 2020 when schools re-opened in England, although the peak number of absences was smaller than in March 2020. This information can help provide context around the absence levels in schools associated with COVID-19. Also, the system has the potential for further development to monitor the impact of other conditions on school absence, e.g. gastrointestinal infections.

show abstract

“…Other work covered the issue of product availability for venom immunotherapy in the UK, 115 epidemiology of allergic and respiratory disease 116‐119 , 120 , 121 occupational allergies, 122‐124 advances in allergy diagnostics 125‐133 , 134 , 135 , 136 , animal model work 137 138 , 139 , 140 , 141 , investigation of infant airway epithelium, 142 a possible association between tree pollen exposure and reduced lung function 143 and evaluations of allergy service delivery 144‐147 …”

Section: Other Areas Of Interestmentioning

confidence: 99%

Developments in the field of allergy in 2020 through the eyes of Clinical and Experimental Allergy

Boyle

Shamji

2021

Clin Experimental Allergy

View full text Add to dashboard Cite

show abstract

Measuring the proportion of and reasons for asthma‐related school absence in England

Cited by 3 publications

References 7 publications

Pharmacogenomics and asthma treatment: acceptability to children, families and healthcare professionals

Pharmacogenomics and asthma treatment: acceptability to children, families and healthcare professionals

Developing a sentinel syndromic surveillance system using school-absenteeism data, example monitoring absences over the 2020 COVID-19 pandemic

Developments in the field of allergy in 2020 through the eyes of Clinical and Experimental Allergy

Contact Info

Product

Resources

About